Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$947M |
| 2 |
Tesla
TSLA
|
+$608M |
| 3 |
Microsoft
MSFT
|
+$444M |
| 4 |
Accenture
ACN
|
+$409M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.06B |
| 2 |
Texas Instruments
TXN
|
+$1.92B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.81B |
| 4 |
Starbucks
SBUX
|
+$1.42B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1,000M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.52% |
| 2 | Financials | 7.13% |
| 3 | Consumer Discretionary | 6.46% |
| 4 | Healthcare | 5.43% |
| 5 | Communication Services | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
APLT
2926
DELISTED
Applied Therapeutics
APLT
| $1.7M | ﹤0.01% |
200,012
+130,102
| +186% | +$767K |
|
2927
CALL
Valley National Bancorp
VLY
$7.9B
| $1.7M | ﹤0.01% |
187,500
-687,500
| -79% | -$5.58M |
|
2928
HealthStream
HSTM
$819M
| $1.7M | ﹤0.01% |
58,838
+34,821
| +145% | +$997K |
|
2929
Eagle Bancorp
EGBN
$846M
| $1.7M | ﹤0.01% |
75,120
+17,051
| +29% | +$358K |
|
|
AAMI
2930
Acadian Asset Management
AAMI
$3.08B
| $1.7M | ﹤0.01% |
66,754
+42,989
| +181% | +$1.03M |
|
|
RWT
2931
Redwood Trust
RWT
$574M
| $1.69M | ﹤0.01% |
218,900
+170,189
| +349% | +$1.24M |
|
2932
Hovnanian Enterprises
HOV
$726M
| $1.69M | ﹤0.01% |
8,274
+6,446
| +353% | +$1.24M |
|
2933
Virtu Financial
VIRT
$5.11B
| $1.69M | ﹤0.01% |
55,486
+20,843
| +60% | +$594K |
|
2934
PUT
Core Scientific
CORZ
$6.66B
| $1.69M | ﹤0.01% |
+142,500
| New | +$1.48M |
|
2935
Hyster-Yale Materials Handling
HY
$599M
| $1.69M | ﹤0.01% |
26,492
+4,226
| +19% | +$276K |
|
2936
AB InBev
BUD
$170B
| $1.69M | ﹤0.01% |
25,456
-154,315
| -86% | -$9.52M |
|
2937
Energy Recovery
ERII
$446M
| $1.68M | ﹤0.01% |
96,677
+76,393
| +377% | +$1.21M |
|
2938
iShares MSCI Saudi Arabia ETF
KSA
$623M
| $1.68M | ﹤0.01% |
39,316
-5,700
| -13% | -$238K |
|
2939
United Natural Foods
UNFI
$3.08B
| $1.68M | ﹤0.01% |
99,757
+77,579
| +350% | +$1.11M |
|
|
ACLX
2940
CALL
DELISTED
Arcellx
ACLX
| $1.67M | ﹤0.01% |
+20,000
| New | +$1.33M |
|
|
ACLX
2941
PUT
DELISTED
Arcellx
ACLX
| $1.67M | ﹤0.01% |
+20,000
| New | +$1.33M |
|
2942
PUT
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.9B
| $1.66M | ﹤0.01% |
+20,000
| New | +$1.61M |
|
2943
HCI Group
HCI
$2.23B
| $1.66M | ﹤0.01% |
15,501
+6,756
| +77% | +$641K |
|
2944
Vicor
VICR
$9.56B
| $1.66M | ﹤0.01% |
39,397
+30,863
| +362% | +$1.15M |
|
2945
National Grid
NGG
$80.4B
| $1.66M | ﹤0.01% |
25,256
-63,671
| -72% | -$3.9M |
|
2946
MidCap Financial Investment
MFIC
$787M
| $1.66M | ﹤0.01% |
123,634
+123,569
| +190,106% | +$1.75M |
|
|
NOVA
2947
DELISTED
Sunnova Energy
NOVA
| $1.65M | ﹤0.01% |
169,449
+60,229
| +55% | +$532K |
|
2948
CALL
Warner Bros
WBD
$65.9B
| $1.65M | ﹤0.01% |
200,000
-1,530,500
| -88% | -$12M |
|
2949
Yext
YEXT
$547M
| $1.65M | ﹤0.01% |
238,361
+137,921
| +137% | +$767K |
|
2950
CALL
Thor Industries
THO
$3.9B
| $1.65M | ﹤0.01% |
+15,000
| New | +$1.52M |
|
Similar funds
Barclays's Q3 2024 Portfolio in Review
As of Q3 2024, Barclays held 5,593 positions worth $377B, up 15% from $327B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $31.3B of net new capital in Q3 2024, opening 785 new positions and adding to 2,954 existing holdings. Its largest new stake was Smurfit Westrock: 3,460,710 shares worth $171M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $2.06B trimmed.
- Barclays's largest Q3 2024 buy was Smurfit Westrock: 3,460,710 shares worth $171M.
- Barclays added most to iShares US Real Estate ETF in Q3 2024, an estimated $947M increase.
- Barclays's biggest Q3 2024 reduction was CRH, cutting an estimated $2.06B.
- Barclays fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $51.3M.
- Barclays's ten largest holdings make up 41% of its $377B portfolio in Q3 2024.
- Barclays opened 785 new positions and closed 322 in Q3 2024.
- Barclays's portfolio value rose 15% quarter-over-quarter to $377B.
Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.